Recent News

Gaps found in use of Herceptin to treat breast cancer

Gaps found in use of Herceptin to treat breast cancer

A potentially life-saving breast cancer treatment was part of the care plan for one Orange County woman, but UNC Lineberger researchers have found gaps in how the treatment is used nationwide.

Gaps found in use of Herceptin to treat breast cancer - Read More…

UNC among nation’s top-ranked cancer hospitals, first in North Carolina

UNC among nation’s top-ranked cancer hospitals, first in North Carolina

The N.C. Cancer Hospital, clinical home of UNC Lineberger Comprehensive Cancer Center, continues to climb higher in U.S. News’ Best Hospitals rankings.

UNC among nation’s top-ranked cancer hospitals, first in North Carolina - Read More…

Cancer cells continue abnormal growth by activating error-prone DNA synthesis

Cancer cells continue abnormal growth by activating error-prone DNA synthesis

UNC Lineberger researchers led by Cyrus Vaziri, PhD, describe the discovery of how a specific cellular protein present in cancer cells triggers a repair mechanism that allows them to DNA damage tolerance and abnormal growth.

Cancer cells continue abnormal growth by activating error-prone DNA synthesis - Read More…

Basch receives $5.45M grant to study patient-reported outcomes

Basch receives $5.45M grant to study patient-reported outcomes

Ethan Basch, MD, MSc, will use a five-year, $5.45 million grant from the Patient-Centered Outcomes Research Institute to support his national study on whether having cancer patients self-report their symptoms while undergoing treatment results in better care.

Basch receives $5.45M grant to study patient-reported outcomes - Read More…